|
|
||||||||
Renal Section, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030
Differential display
RT-PCR cloning method was applied to poly(A)+ RNA isolated
from Madin-Darby canine kidney (MDCK) cells in isotonic or hypertonic
medium. A differentially expressed 360-bp PCR fragment was isolated,
subcloned, sequenced, and used to screen an MDCK cDNA library
constructed in
ZapII. A composite sequence of two overlapping cDNA
clones provided 1,053 bp of sequence that was 93% identical to human
stanniocalcin and corresponded to the 3'-end of the mRNA.
Although the fish homolog of this hormone inhibits calcium uptake by
the gill and intestine, the function of mammalian stanniocalcin remains
unknown. Stanniocalcin cDNA probe hybridizes to a 4.4-kb mRNA that is
induced eightfold by hypertonicity, in a manner that is dependent on
medium organic osmolytes. The mRNA induction correlates with increased
total cellular content of the protein and its concomitant release to
the medium, consistent with secretion for autocrine or paracrine
activity. Furthermore, induction of the mRNA by hypertonicity is
dependent on extracellular calcium and displays a threshold phenomenon.
The data suggest that kidney stanniocalcin may have a role in the
adaptation of kidney cells to osmotic stress, in a manner that is
extracellular calcium dependent.
kidney; osmotic stress; calcium; Madin-Darby canine kidney cells; thick ascending limb
This article has been cited by other articles:
![]() |
S. Raulic, Y. Ramos-Valdes, and G. E DiMattia Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro J. Endocrinol., June 1, 2008; 197(3): 517 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Sazonova, K. A. James, C. R. McCudden, D. Segal, A. Talebian, and G. F. Wagner Stanniocalcin-1 secretion and receptor regulation in kidney cells Am J Physiol Renal Physiol, April 1, 2008; 294(4): F788 - F794. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva Cellular Response to Hyperosmotic Stresses Physiol Rev, October 1, 2007; 87(4): 1441 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ito, J. R. Walker, C. S. Thompson, I. Moroz, W. Lin, M. L. Veselits, A. M. Hakim, A. A. Fienberg, and G. Thinakaran Characterization of Stanniocalcin 2, a Novel Target of the Mammalian Unfolded Protein Response with Cytoprotective Properties Mol. Cell. Biol., November 1, 2004; 24(21): 9456 - 9469. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kanellis, R. Bick, G. Garcia, L. Truong, C. C. Tsao, D. Etemadmoghadam, B. Poindexter, L. Feng, R. J. Johnson, and D. Sheikh-Hamad Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis Am J Physiol Renal Physiol, February 1, 2004; 286(2): F356 - F362. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sheikh-Hamad, R. Bick, G.-Y. Wu, B. M. Christensen, P. Razeghi, B. Poindexter, H. Taegtmeyer, A. Wamsley, R. Padda, M. Entman, et al. Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H442 - H448. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ishibashi and M. Imai Prospect of a stanniocalcin endocrine/paracrine system in mammals Am J Physiol Renal Physiol, March 1, 2002; 282(3): F367 - F375. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |